Hepatitis B Vaccine Administration Guidelines

Core Management Principles

The Centers for Disease Control and Prevention (CDC) recommends that when the hepatitis B vaccine series is interrupted at any point, the series is never restarted, and the delayed dose should be administered as soon as possible, with proper timing intervals 1, 2, 3, 4
The Advisory Committee on Immunization Practices (ACIP) provides guidance that the series does not need to be restarted, and protection will be achieved once the dose is given with proper timing intervals 1, 2, 3

The delayed third dose of hepatitis B vaccine should be administered at least 8 weeks after the second dose, and at least 16 weeks after the first dose, with a 4-day grace period applicable, except for the accelerated Twinrix schedule 1, 2, 3, 6
For infants, the third dose should not be given before 24 weeks of age, regardless of when earlier doses were given 2, 3, 6

The CDC recommends that healthcare personnel and public safety workers with potential blood/body fluid exposure should receive the delayed third dose urgently 2, 3
Hemodialysis patients, household or sexual contacts of HBsAg-positive persons, HIV-infected persons, and other immunocompromised individuals should also receive the delayed third dose urgently 2, 3, 4
Persons born in countries with HBV endemicity ≥2% should receive the delayed third dose urgently 5

For high-risk groups, anti-HBs levels should be measured 1-2 months after completing the delayed third dose, with seroprotection defined as anti-HBs ≥10 mIU/mL 2, 3, 6
If non-response occurs (anti-HBs <10 mIU/mL), consider revaccination with an alternative vaccine or high-dose formulation 5

For Twinrix (combination hepatitis A/B), the final 12-month dose is crucial for long-term immunity and should be administered as soon as possible if delayed, with no 4-day grace period applicable to the first three doses of the accelerated schedule 1, 7